Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03708965 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv9
  2. Primary completion date: Mar 31, 2024 to Dec 31, 2026
    • Study completion date: Mar 31, 2024 to Dec 31, 2027
    v8
  3. Primary and study completion dates: Dec 31, 2026 to Mar 31, 2024
    • Secondary endpoints: details revised at 6 of 6 entries
    v7
  4. Re-verified, no change to tracked fieldsv6
  5. Enrollment target: estimated 18 to confirmed 19
    • Secondary endpoints: details revised at 6 of 6 entries
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: May 31, 2021 to Dec 31, 2026v4
  2. Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Study completion date: May 31, 2021 to Dec 31, 2026
    v3
  3. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 2
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Phase II open-label, parallel group, 2 sites (Brazil), designed to evaluate the long term safety and efficacy of study drug for the treatment of the MPS II.
Trial Details
NCT Number NCT03708965
Lead Sponsor JCR Pharmaceuticals Co., Ltd.
Conditions
(from sponsor)		 Mucopolysaccharidosis II
Related terms Mucopolysaccharidosis II
Enrollment 19 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov